Binding of equine infectious anemia virus Rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs

Molecular and Cellular Biology

Volumn 20, Issue 10, 2000, Pages 3550-3557

  Belshan, Michael ^a   Park, Gregory S ^a   Bilodeau, Patricia ^b   Stoltzfus, C Martin ^b   Carpenter, Susan ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; ENHANCER REGION; EXON; GENE MUTATION; HORSE DISEASE; NONHUMAN; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; BINDING SITES; BIOLOGICAL TRANSPORT; CELL NUCLEUS; EXONS; GENE PRODUCTS, REV; INFECTIOUS ANEMIA VIRUS, EQUINE; MUTAGENESIS; NUCLEAR PROTEINS; PROTEIN BINDING; RNA, MESSENGER; RNA, VIRAL;

EID: 0034096383     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.10.3550-3557.2000     Document Type: Article

References (35)

1. Ali, S. A., and A. Steinkasserer. 1995. PCR-ligation-PCR mutagenesis: a protocol for creating gene fusions and mutations. Biotechniques 18:746-750.
2. Amendt, B. A., D. Hesslein, L.-J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14:3960-3970.
3. Beisel, C. E., J. F. Edwards, L. L. Dunn, and N. R. Rice. 1993. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J. Virol. 67:832-842.
4. Belshan, M., M. E. Harris, A. E. Shoemaker, T. J. Hope, and S. Carpenter. 1998. Biological characterization of Rev variation in equine infectious anemia virus. J. Virol. 72:4421-4426.
5. Carpenter, S., S. Alexandersen, M. J. Long, S. Perryman, and B. Chesebro. 1991. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 65:1605-1610.
6. Carroll, R., and D. Derse. 1993. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon. J. Virol. 67:1433-1440.
7. Cochrane, A. W., C.-H. Chen, and C. A. Rosen. 1990. Specific interaction of the human immunodeficiency virus rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 87:1198-1202.
8. Cook, K. S., G. J. Fisk, J. Hauber, N. Usman, T. J. Daly, and J. R. Rusche. 1991. Characterization of human immunodeficiency virus type 1 protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19: 1577-1583.
9. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
10. Daly, T. J., R. C. Doten, P. Rennert, M. Auer, H. Jaksche, A. Donner, G. Fisk, and J. R. Rusche. 1993. Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry 32:10497-10505.
11. Dayton, E. T., D. A. M. Konings, D. M. Powell, B. A. Shapiro, L. Butini, J. V. Maizel, and A. I. Dayton. 1992. Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J. Virol. 66:1139-1151.
12. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
13. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattal, and R. Luhrmann. 1995. The HIV-1 rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
14. Fridell, R. A., H. P. Bogerd, and B. R. Cullen. 1996. Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl. Acad. Sci. USA 93:4421-4424.
15. Fridell, R. A., K. M. Partin, S. Carpenter, and B. R. Cullen. 1993. Identification of the activation domain of equine infectious anemia virus Rev. J. Virol. 67:7317-7323.
16. Fu, X.-D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680.
17. Gontarek, R. R., and D. Derse. 1996. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell. Biol. 16:2325-2331.
18. Harris, M. E., R. R. Gontarek, D. Derse, and T. J. Hope. 1998. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein. Mol. Cell. Biol. 18:3889-3899.
19. Jacks, T., H. D. Madhani, F. R. Masiarz, and H. E. Varmus. 1988. Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell 55: 447-458.
20. Kawakami, T., L. Sherman, J. Dahlbert, A. Gazit, A. Yaniv, S. R. Tronick, and S. A. Aaronson. 1987. Nucleotide sequence analysis of equine infectious anemia proviral DNA. Virology 158:300-312.
21. Krainer, A. R., A. Mayeda, D. Kozak, and G. Binns. 1991. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 66:383-394.
22. Martarano, L., R. Stephens, N. Rice, and D. Derse. 1994. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68:3102-3111.
23. Mayeda, A., G. R. Screaton, S. D. Chandler, X.-D. Fu, and A. R. Krainer. 1999. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol. Cell. Biol. 19:1853-1863.
24. Olsen, H., A. Cochrane, P. Dillon, C. Nalin, and C. Rosen. 1990. Interaction of the human immunodeficiency virus type 1 rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1357-1364.
25. Olsen, H. S., P. Nelbock, A. W. Cochrane, and C. A. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247:845-848.
26. Olsen, H. S., S. Beidas, P. Dillon, C. A. Rosen, and A. W. Cochrane. 1991. Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element. J. Acquir. Immune Defic. Syndr. 4:558-567.
27. Powell, D. M., M. J. Zhang, D. A. M. Konings, P. T. Wingfield, S. J. Stahl, E. T. Dayton, and A. I. Dayton. 1995. Sequence specificity in the higher-order interaction of the rev protein of HIV-1 with its target sequence, the RRE. J. Acquir. Immune Defic. Syndr. 10:317-323.
28. Powell, D. M., M. C. Amaral, J. Y. Wu, T. Maniatis, and W. C. Greene. 1997. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing. Proc. Natl. Acad. Sci. USA. 94:973-978.
29. Schwartz, S., B. K. Felber, D. M. Benko, E. M. Fenyo, and G. N. Pavlakis. 1990. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:2519-2529.
30. Screaton, G. R., J. F. Caceres, A. Mayeda, M. V. Bell, M. Plebanski, D. G. Jackson, J. I. Bell, and A. R. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:4336-4349.
31. Smith, T. A., E. Davis, and S. Carpenter. 1998. Endotoxin treatment of EIAV-infected horse macrophage cultures decreases production of infectious virus. J. Gen. Virol. 79:747-755.
32. Van Rck, D. I., and S. Venkatesan, 1999. Real-time kinetics of HIV-1 Rev-Rev response element interactions. J. Biol. Chem. 274:17452-17463.
33. Zahler, A. M., K. M. Neugebauer, W. S. Lane, and M. B. Roth. 1993. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219-222.
34. Zapp, M., T. Hope, T. Parslow, and M. Green. 1988. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus rev protein: a dual function for an arginine-rich motif. Proc. Natl. Acad. Sci. USA 88:7734-7738.
35. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342:714-716.